PTC Therapeutics
PTCT
PTCT
176 hedge funds and large institutions have $2.63B invested in PTC Therapeutics in 2019 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 65 increasing their positions, 57 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
14% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 57
1% more funds holding
Funds holding: 174 → 176 (+2)
0.46% less ownership
Funds ownership: 100.37% → 99.91% (-0.46%)
Holders
176
Holding in Top 10
9
Calls
$19.2M
Puts
$14.2M
Top Buyers
| 1 | +$32.7M | |
| 2 | +$31.3M | |
| 3 | +$30.8M | |
| 4 |
RI
RTW Investments
New York
|
+$28M |
| 5 |
O
OrbiMed
New York
|
+$25.7M |
Top Sellers
| 1 | -$50.5M | |
| 2 | -$40.9M | |
| 3 | -$38.3M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$24.9M |
| 5 |
Renaissance Technologies
New York
|
-$24.2M |